GINKGO BIOWORKS HOLDINGS INC (DNA) Stock Institutional Trading Activity


GINKGO BIOWORKS HOLDINGS INC (DNA) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2024), investors with some of the largest reported share count changes include Renaissance Technologies LLC and Viking Global Investors. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2024Renaissance Technologies LLCBuy45,200114,654$1,125,902
Q3 2024Renaissance Technologies LLCBuy69,45469,454$566,050
Q3 2024Viking Global InvestorsBuy3,577,1283,577,128$29,153,593

Frequently asked questions about DNA activity

  • Which institutional owners are buying DNA?

    Institutional owners buying DNA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in DNA activity?

    "Buy" means an investor increased their reported position in DNA compared to the prior reporting period. This reflects growing exposure to GINKGO BIOWORKS HOLDINGS INC (DNA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in DNA increasing?

    Institutional interest in DNA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.